With capital and credit markets on the rebound, and less than 100 days until the US presidential election, mid-market M&A activity is rapidly emerging from months of involuntary hibernation. On the heels of a moribund spring and early summer, August’s arrival yielded significant deals within the healthcare, biopharmaceutical and technology sectors, and industry observers remain bullish on an equally robust Q4 for manufacturing, financial services, energy, consumer goods and beyond. This September, the Thomson Reuters Institute is pleased to present a five-part, week-long exploration of the US middle-market deals environment in the shadow of COVID-19. Our diverse and experienced faculty offers important guidance on emerging opportunities and regulatory considerations for M&A professionals across the nation.
Sign up today and gain access to all five sessions! Online registration now available.
*Please be advised, we are unable to offer CLE accreditation for this year’s program.